The late neurocognitive and psychosocial effects of treatment for pediatric brain tumor (PBT)
represent important areas of clinical focus and ongoing research. Neurocognitive sequelae …

Context Although cognitive impairments have been identified in patients with non–central
nervous system cancer, especially breast cancer, the respective roles of cancer and …

Pediatric oncology psychosocial professionals collaborated with an interdisciplinary group
of experts and stakeholders and developed evidence‐based standards for pediatric …

Central nervous system cancers or exposure to CNS‐directed therapies increase risk for
neuropsychological deficits. There are no accepted guidelines for assessment of …

Background Patients treated for medulloblastoma who experience posterior fossa syndrome
(PFS) demonstrate increased risk for neurocognitive impairment at one year post diagnosis …

Purpose To report, from a longitudinal study, cognitive outcome in pediatric patients treated
with proton radiation therapy (PRT) for central nervous system (CNS) tumors. Methods and …

Pediatric brain tumor (BT) survivors are at risk for psychosocial late effects across many
domains of functioning, including neurocognitive and social. The literature on the social …

Purpose Radiation therapy is integral in treatment of pediatric brain tumors, but it is
associated with negative long-term sequelae. Proton beam radiation therapy (PRT), which …

Purpose Improved therapies for pediatric central nervous system (CNS) tumors have
increased survival rates; however, many survivors experience significant long-term …

Importance Despite advancements in cancer therapy and supportive care, childhood cancer
survivors remain at risk for chronic morbidities associated with disease and treatment, such …